New Data in Simultaneous Pancreas-Kidney Transplantation Fur

New Data in Simultaneous Pancreas-Kidney Transplantation Further Demonstrates the Value of Prospera dd-cfDNA Technology

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that a study1 reporting on the performance of...

Related Keywords

California , United States , Spain , Texas , Barcelona , Comunidad Autonoma De Cataluna , San Carlos , Pedro Ventura Aguiar , Bernie Tobin , Mike Brophy , Kate Stabrawa , Natera Inc , Clinical Laboratory Improvement Amendments , Prnewswire Natera Inc , Drug Administration , Nasdaq , Hospital Clinic , Natera , Nc ,